Envoy Medical, Inc. COCH
Set alert
6.63 USD +0.13 +2.00%
At close · Oct 30
6.63 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
6.26 Day range 6.70
3.90 52-week range 9.01
- YTD
- +0.30%
- 1 year
- -11.48%
- Open
- 6.28
- Prev close
- 6.50
- Mkt cap
- 51.31M
- Vol
- 48.37K
- Avg vol
- 11.89K
- EPS
- -7.60
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.26
- High
- 6.70
- Forward P/E
- -1.43
- Beta
- 2.36
- Short ratio
- 1.75
- Inst. own
- 6.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 2.25
- 200-d avg
- 3.10
- 1y target
- 6.50
6M chart
Events in this range
- Oct 26, 2026Split: 1 for 10
Signals (54)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 27, 2026 | 5 days ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 1 month ago |
| SMA: Bearish | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| SMA: Bullish | Jul 22, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 17, 2026 | 3 months ago |
| SMA: Bullish | Jul 14, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jul 13, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 10, 2026 | 3 months ago |
| SMA: Bearish | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jul 9, 2026 | 3 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 27, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | May 18, 2026 | 5 months ago |
| MACD: Sell Signal | May 8, 2026 | 5 months ago |
| SMA: Bearish | May 6, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | May 1, 2026 | 6 months ago |
Key statistics
- Market cap
- 32.39M
- Enterprise value
- 48.59M
- Trailing P/E
- 0.00
- Forward P/E
- -1.43
- PEG ratio
- 0.00
- Price / sales
- 107.26
- Price / book
- 0.00
- EPS (TTM)
- -1.28
- Beta
- 2.36
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 302.00K
- Revenue growth
- 7.90%
- Free cash flow
- -8.05M
- Total cash
- 1.75M
- Total debt
- 8.59M
- Return on equity
- 0.00%
- Shares outstanding
- 20.24M
- Short % of float
- 0.65%
- 50-day average
- 2.25
- 200-day average
- 3.10
Analyst view
Consensus: none
Price target (mean) 6.50 -2.0% downside
Now 6.63
- Target (low)
- 5.00
- Target (mean)
- 6.50
- Target (high)
- 9.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 12, 2024
Expected Aug 12, 2024. Consensus EPS estimate -0.31333.
Financials — quick view
COCH Revenue — quarterly 51.00K
COCH Net income — quarterly -5.98M
COCH EPS — quarterly -0.70
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | -0.27 | -0.37 | -0.10 | -37.04% |
| Aug 12, 2024 | Jun 1, 2024 | -0.24 | — | — | — |
| Aug 12, 2024 | Jun 1, 2024 | -0.24 | -0.27 | -0.03 | -12.50% |
| May 15, 2024 | Mar 1, 2024 | -0.19 | — | — | — |
| May 15, 2024 | Mar 1, 2024 | -0.19 | -0.32 | -0.13 | -68.42% |
| Apr 5, 2024 | Dec 1, 2023 | -0.19 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 6, 2024 | Ascendiant Capital | main | Buy | Buy |
| Oct 14, 2024 | Brookline Capital | init | — | Buy |
| Sep 3, 2024 | Ascendiant Capital | main | Buy | Buy |
| Jun 24, 2024 | Ascendiant Capital | init | — | Buy |
| Apr 3, 2024 | Lake Street | main | Buy | Buy |
| Dec 21, 2023 | Northland Capital Markets | init | — | Outperform |
About Envoy Medical, Inc.
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- envoymedical.com
News
- Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th
- Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
- Envoy Medical Announces 1-For-10 Reverse Stock Split, Effective Oct. 26
- Envoy Medical Announces Reverse Stock Split
- Envoy Medical Surpasses 6-Month Follow-Up Visit Milestone For Pivotal Clinical Trial Evaluating Investigational Fully Implanted Acclaim Cochlear Implant; Expects To Submit Final Clinical PMA Module By End Of Q2 2027
- Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design
- Envoy Medical Submits Second FDA Module Of Its PMA Application For The Acclaim Cochlear Implant; Targets Final Clinical Submission In Q2 2027
- Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant
- Envoy Medical Announces Delaware Chancery Court Dismissal With Prejudice Of Atlas Merchant Capital Spac Fund I's Claim That It Was Not Allowed To Redeem Shares
- Lake Street Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5
Your note
Sign in to keep a note on COCH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANZU SPAC GP I L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 28, 2023 | 0 |
| DEWBREY DIANE L | Director | Conversion of Exercise of derivative security | Sep 28, 2023 | 25,000 |
| HIRSCH DANIEL J | Chief Financial Officer | Conversion of Exercise of derivative security | Sep 28, 2023 | 25,000 |
| HUSKINS PRIYA CHERIAN | Director | Conversion of Exercise of derivative security | Sep 28, 2023 | 25,000 |
| KANTOR SUSAN J. | Director | Conversion of Exercise of derivative security | Sep 28, 2023 | 25,000 |
| LUCAS BRENT T | Chief Executive Officer | Purchase | Nov 20, 2023 | 131,338 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Atlas Merchant Capital LLC | 2.74% | 555,527 | 888.84K | Sep 29, 2024 |
| Vanguard Group Inc | 0.92% | 185,961 | 297.54K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.44% | 88,544 | 141.67K | Sep 29, 2024 |
| HighPoint Advisor Group LLC | 0.19% | 38,662 | 61.86K | Sep 29, 2024 |
| Corient Private Wealth LLC | 0.19% | 38,162 | 61.06K | Sep 29, 2024 |
| Morgan Stanley | 0.16% | 31,541 | 50.47K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.55% | 112,140 | 179.42K | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 0.35% | 70,033 | 112.05K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.20% | 39,484 | 63.17K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 13,277 | 21.24K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.07% | 14,692 | 23.51K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.07% | 13,654 | 21.85K | Oct 30, 2024 |